|
|
||||||||
Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas 66506; and Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska 68198
| |
ABSTRACT |
|---|
|
|
|---|
Autospectral and coherence
analyses were used to determine the effect of paraventricular nucleus
(PVN) GABAA receptor antagonism [microinfusion or
microinjections of bicuculline methiodide (BMI) 100 pmoles] on
sympathetic nerve discharge (SND) frequency components (bursting
pattern and relationships between discharges in regionally selective
nerves) in
-chloralose-anesthetized rats. SND was recorded from the renal, splenic, and lumbar nerves. The following observations were made. First, PVN BMI microinjections, but not PVN saline or
cortical BMI microinjections, transformed the cardiac-related SND
bursting pattern in baroreceptor-innervated rats to one characterized by the presence of low-frequency bursts not synchronized to the cardiac
cycle or phrenic nerve discharge bursts. Second, SND pattern changes
were similar in the renal, splenic, and lumbar nerves, and peak
coherence values relating low-frequency bursts in sympathetic nerve
pairs (renal-splenic, renal-lumbar, and splenic-lumbar) were
significantly increased from preinjection control after PVN BMI
microinjection. Third, PVN BMI microinjections significantly increased
the coupling between low-frequency SND bursts in
baroreceptor-denervated rats. Finally, PVN BMI-induced changes in the
SND bursting pattern were not observed after PVN pretreatment with
muscimol (GABA agonist, 1 nmole). We conclude that PVN
GABAA receptor antagonism profoundly alters the frequency
components in sympathetic nerves.
sympathetic nerve activity; autospectral analysis; coherence function; Sprague-Dawley rats
| |
INTRODUCTION |
|---|
|
|
|---|
IT IS WELL ESTABLISHED that GABA plays a role in the central regulation of arterial blood pressure and sympathetic nerve discharge (SND) (10). Microinjection of muscimol, a GABA agonist, into the paraventricular nucleus (PVN) of the hypothalamus decreases arterial pressure and renal SND (28). In contrast, microinfusion or microinjection of bicuculline methiodide (BMI), a GABAA receptor antagonist, into the PVN increases arterial pressure (7, 20-22, 26, 28), heart rate (HR) (7, 20-22, 26), cardiac index (20), plasma concentrations of norepinephrine and epinephrine (21, 22), and renal SND (26, 28). These findings suggest that a PVN GABAergic system exerts a tonic inhibitory effect on efferent SND (20, 22).
The role of the PVN GABAergic system in control of the pattern of SND is not known. This is an important omission because the SND bursting pattern represents the signature output of central sympathetic neural circuits (1, 8, 9) and can be changed during a variety of experimental interventions (3, 12, 14, 15). In addition, the effect of PVN GABAA receptor antagonism on the frequency-domain relationships between discharges in sympathetic nerve pairs is not known. Importantly, synchronized discharges in sympathetic nerves can uncouple during various experimental interventions (3, 12), demonstrating one form of sympathetic selectivity. Because the PVN is an important central nervous system site for autonomic and endocrine regulation (19, 23, 25), we hypothesized that PVN BMI microinjection would alter the SND bursting pattern and the frequency-domain coupling between discharges in sympathetic nerve pairs (i.e., renal-splenic, renal-lumbar, and splenic-lumbar).
With the exception of renal SND (26, 28), the effect of PVN GABAA receptor antagonism on the level of activity in other sympathetic nerves is not well established. This is an important omission because it is widely accepted that the sympathetic nervous system can selectively change the level of activity in nerves that innervate different target organs (2, 4, 11, 13, 15, 27). Relative to this point, Deering and Coote (6) reported that in anesthetized rabbits, PVN injections of DL-homocysteic acid decreased the level of renal SND but increased splanchnic, adrenal, and cardiac SND. We hypothesized that PVN microinjection of BMI would produce nonuniform changes in the level of renal, splenic, and lumbar SND (as evidenced by directionally opposite changes in the level of SND and/or differences in the time course of SND responses).
| |
METHODS |
|---|
|
|
|---|
Surgical procedures and experimental protocols were approved by the Institutional Animal Care and Use Committee.
General procedures.
Male Sprague-Dawley rats (300 g) were anesthetized (methohexital
sodium, 50-60 mg/kg ip, followed by
-chloralose 50 mg/kg iv,
initial dose), artificially ventilated, and paralyzed with gallamine
triethiodide (5-10 mg/kg iv, initial dose). Catheters were placed
in the femoral vein for administering drugs, including maintenance
doses of
-chloralose (35 mg · kg
1 · h
1),
methohexital sodium (10-20 mg/kg), and gallamine triethiodide (10-15 mg · kg
1 · h
1).
End-tidal CO2 was kept near 4.5% by adjusting the
frequency of respiration. Colonic temperature was measured and was kept at 38.0°C during surgery by a temperature-controlled table. Femoral arterial blood pressure and HR were recorded using standard procedures.
Neural recordings. Activity was recorded biphasically with a platinum bipolar electrode after capacity-coupled preamplification (band pass 30-3,000 Hz) from the central end of cut renal, splenic, and lumbar sympathetic nerves. The renal and splenic nerves were isolated retroperitoneally and the lumbar nerve was isolated after a midline laparotomy. The left phrenic nerve was isolated in the cervical region. The nerve electrode preparations were covered with a silicone gel. The sympathetic and phrenic nerve potentials were full-wave rectified and integrated (time constant 10 ms), which produced a smooth tracing of the synchronized discharges (14-16). The level of activity in sympathetic nerves was quantified after integration as volts times seconds and corrected for background noise after ganglionic blockade (trimethaphan camsylate, 15 mg/kg) or nerve crush (14-16).
Central nervous system microinjections. With the use of stereotaxic methods, microinjections of 100 pmoles of BMI dissolved in phosphate-buffered saline (50 nl) or saline (50 nl, vehicle controls) were made unilaterally into the PVN (target site; 1.8 mm caudal to bregma, 0.7 mm lateral to the midline, 7.7 mm ventral from the surface of the brain). The dorsal parvocellular subdivision of the PVN was targeted because this region contains neurons that project to brain stem regions involved in autonomic regulation and to sympathetic preganglionic neurons of the intermediolateral cell column (19, 23, 25). Anatomic controls were completed by microinjecting BMI (100 pmoles, 50 nl) into the frontoparietal motor cortex (1.8 mm caudal to bregma, 0.7 mm lateral to the midline, 2.0 mm ventral from the surface of the brain), an area of the brain that has not been found to be involved in SND regulation. Sites of microinjection were identified with reference to the location of the tip of the micropipette. Rhodamine-labeled latex microspheres (1:2 dilution with distilled water) were mixed with the BMI to identify the diffusion boundaries of the microinjection.
Midbrain transections. The rat was placed in a stereotaxic apparatus and a portion of the skull was removed. Midbrain transections were completed by performing sequential left and right hemisections at the level of the superior colliculus (16). Transections were completed through the rostral portion of the superior colliculus (16). The completeness and level of transection were verified by gross examination of the brain stem.
Brain histology. At the end of each experiment, the rats received an overdose of methohexital sodium (150 mg/kg iv) and were transcardially perfused with 0.15 M NaCl (containing 3 IU/ml heparin) followed by a fixative solution consisting of 10% buffered neutral formalin (pH 7.4). Brains were removed and blocked, and a fiducial mark was made in the right hemisphere. Brains were postfixed in buffered neutral formalin for at least 2 h and then placed in 20% sucrose for cyroprotection. Once the brains sank in the sucrose, they were frozen, sectioned at 40 µm in the coronal plane, collected into phosphate-buffered saline, and mounted on subbed slides in serial sequence. The sections were rinsed in distilled water, air dried, cleared in xylenes, and coverslipped. The center of the injection site was localized by observing discrete clusters of latex microspheres. Microspheres could be observed in bright field or epifluoresence (rhodamine filter cube: BP 515-560 excitation filter).
Data and statistical analysis. Autospectra and coherence analysis of the arterial pulse, SND, and phrenic nerve discharge (PND) were computed using the methods and programs described earlier (17). Fast Fourier transform was performed on 12-18 contiguous windows of data that were 5 s in duration. Autospectra and coherence functions were computed over a frequency band of 0-15 Hz. Spectral analyses provide the following information (17). The autospectrum of a signal shows the relative power present at each frequency. The coherence function (normalized cross spectrum) provides a measure of the strength of linear correlation of two signals as a function of frequency. The squared coherence value (referred to as coherence value) is 1.0 in the case of a linear system undisturbed by noise and is zero, if the two signals are completely unrelated. Peak coherence values in the 0- to 2-Hz frequency band and at the frequency of HR (cardiac frequency) were quantified.
All values are means ± SE. Control values of SND were taken as 100%. Statistical analysis included Student's t-test for pairwise comparisons and repeated-measures analysis of variance. P < 0.05 indicated statistical significance.| |
RESULTS |
|---|
|
|
|---|
The effect of PVN BMI microinjections (100 pmoles, 50 nl) on SND
frequency components, the level of sympathetic nerve activity, MAP, and
HR was determined in 15 baroreceptor-innervated rats and four SAD rats.
In baroreceptor-innervated rats, SND was recorded simultaneously from
three nerves (renal-splenic-lumbar) in five experiments and from two
nerves (renal-splenic, n = 7; renal-lumbar, n = 1; splenic-lumbar, n = 2) in 10 experiments. Six of the renal-splenic SND recording experiments also
included PND recordings. SND was recorded from renal-splenic
sympathetic nerve pairs in SAD rats (n = 4). PVN saline
microinjections (50 nl, n = 8, administered before PVN
microinjection of BMI) and cortical BMI microinjections (100 pmoles in
50 nl, n = 9) were completed in baroreceptor-innervated rats. Figure 1 shows BMI microinjection
sites (as referenced to the tip of the micropipette) in
baroreceptor-innervated and SAD rats from the rostral to caudal extent
of the PVN and vicinity. In every experiment, the PVN was included
within the diffusion boundaries of the microinjection. Therefore, we
refer in RESULTS to PVN microinjections.
|
Figure 2A shows traces of
simultaneously recorded SND bursts (renal, splenic, and lumbar) and
pulsatile arterial pressure from a representative experiment during
control and 45 s, 6 min, and 30 min (recovery) after PVN BMI
microinjection. MAP values recorded during each period are shown below
the pulsatile arterial pressure traces. During control, the majority of
SND bursts were coupled to the arterial pulse. In contrast, renal,
splenic, and lumbar nerve recordings were dominated by the presence of
low-frequency bursts at 45 s and 6 min postinjection. During
recovery, SND bursts were similar to control. MAP was increased from
control at 45 s and 6 min after PVN BMI microinjection. PVN
BMI-induced changes in the SND bursting pattern were not observed after
pretreatment with muscimol (GABA agonist, 1 nmole, n = 4) (see Fig. 2B for one representative example). In
contrast, when BMI microinjections were repeated at the same PVN site
without an intervening muscimol microinjection, the SND bursting
pattern was changed (similar to Fig. 2A) after each PVN BMI
microinjection (n = 3). PVN muscimol did not
significantly change MAP (
10 ± 4 mmHg, P < 0.09) or the level of renal (+4 ± 3%) and splenic (
2 ± 3%) SND.
|
Figure 3 shows the results of autospectral and coherence analyses of
lumbar, renal, and splenic SND (12 contiguous windows of data that were
5 s in duration) during control (A) and initiated at
20 s (B), 6 min (C), and 30 min
(D) after PVN BMI microinjection from one representative
experiment. During control, SND autospectra (Fig.
3, A,
left) contained primary peaks at the frequency of the HR
(8.0 Hz) and SND coherence functions (Fig. 3, A,
right) demonstrated correlations that extended from 0 to
~10 Hz, with peaks at 8 Hz and at frequencies <4 Hz. After PVN BMI
microinjection (20 s and 6 min), the primary peaks in the SND
autospectra were shifted to <2 Hz (Fig. 3,
B-C, left), cardiac-related peaks
in the SND coherence functions were reduced (Fig. 3,
B-C, right), and peak coherence
values relating low-frequency (0-2 Hz) discharges were increased
(Fig. 3, B-C, right). SND
autospectra (Fig. 3D, left) and coherence
functions (Fig. 3D, right) constructed 30 min
after PVN BMI were similar to control. Onset of the SND pattern change
after PVN BMI microinjection, as documented by a shift in the SND
autospectra, was 40 ± 6 s in baroreceptor-innervated rats
(n = 15).
|
Mean data from PVN BMI microinjection experiments in
baroreceptor-innervated rats were analyzed at the following three
points: 1) preinjection control; 2) after
microinjection when changes in SND frequency components (5 ± 1 min), MAP (5 ± 1 min), and the level of sympathetic nerve
activity (11 ± 2 min) were maximal (max change); and
3) recovery (19 ± 3 min after microinjection). Peak
coherence values relating low-frequency (0- to 2-Hz frequency band)
discharges in sympathetic nerve pairs (renal-splenic, renal-lumbar, and
splenic-lumbar) were significantly increased, whereas those relating
discharges at the cardiac frequency were significantly reduced after
PVN BMI (Table 1). Peak coherence values
remained unchanged from control after PVN saline and cortex BMI
microinjections. MAP and the level of renal and splenic SND were
significantly increased, whereas HR and lumbar SND remained unchanged
from control after PVN BMI (Table 2).
MAP, HR, and the level of SND (renal, splenic, and lumbar) remained
unchanged from control after PVN saline and cortex BMI microinjections.
|
|
The effect of PVN BMI microinjection (100 pmoles) on the coupling
between SND and PND bursts (renal-phrenic and splenic-phrenic) was determined in six baroreceptor-innervated rats. Renal,
splenic, and phrenic nerve autospectra (Fig.
4, A and B,
left) and SND-PND coherence functions (Fig. 4, A
and B, right) were constructed before and after
PVN BMI microinjection. During control (Fig. 4A), SND
autospectra contained peaks at HR (7.6 Hz) and PND (1.2 Hz, small in
the renal SND autospectrum and large in the splenic SND autospectrum)
frequencies. In addition, SND-PND coherence functions constructed
during control had primary peaks (renal-phrenic, 0.44 and
splenic-phrenic, 0.83) at 1.2 Hz. After PVN BMI microinjection (Fig.
4B), cardiac-related peaks in the SND autospectra were
reduced, and peak coherence values relating SND-PND bursts were
virtually eliminated. Peak coherence values relating renal-phrenic
(control, 0.56 ± 0.11 and max change, 0.07 ± 0.02, n = 6) and splenic-phrenic (control, 0.61 ± 0.08 and max change, 0.08 ± 0.01, n = 6) were significantly reduced from control after PVN BMI microinjections.
|
Midbrain transections were completed after PVN BMI microinjection in
three baroreceptor-innervated rats. Figure
5 shows traces of simultaneously recorded
renal and splenic SND during control (A), 5 min after PVN
BMI microinjection (B), and immediately after decerebration
(completed within 10 min after PVN BMI microinjection) (C).
Renal and splenic SND were dominated by the presence of low-frequency bursts 5 min after PVN BMI microinjection, whereas immediately after
completion of the transection procedure, SND bursts were similar to
control. Similar results were observed in each of the midbrain
transection experiments.
|
The effect of PVN BMI microinjection (100 pmoles) on SND
(renal-splenic) frequency components, the level of SND, MAP, and HR was
determined in four SAD rats. The results of autospectral and coherence
analyses of renal and splenic SND from a representative experiment are
shown in Fig. 6. During control
(A), SND autospectra contained primary peaks between 0 and 3 Hz and were devoid of cardiac-related peaks (7.0 Hz in this
experiment), and the renal-splenic coherence function had peak values
between 0 and 3 Hz. SND autospectra exhibited narrow bands, and peak
coherence values were markedly increased after PVN microinjection (Fig.
6B). Onset of the SND pattern change after PVN BMI
microinjection was 40 ± 17 s in SAD rats (n = 4). Peak coherence values relating renal-splenic discharges in the 0- to 2-Hz frequency band (control, 0.68 ± 0.5 and 5-7 min
after PVN BMI, 0.96 ± 0.01) and MAP (control, 93 ± 16 mmHg and 5-7 min after PVN BMI, 155 ± 28 mmHg) were significantly
increased after PVN BMI microinjection in SAD rats. In addition, the
level of renal SND was increased by 118 ± 52% (P < 0.05), and the level of splenic SND was increased by 105 ± 54% (P < 0.05) after PVN BMI microinjection in SAD
rats.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study examined the effect of PVN GABAA receptor antagonism on efferent sympathetic nerve outflow in chloralose-anesthetized rats. Our results provide experimental support for three findings that provide insight into the role of the PVN in sympathetic nerve regulation. First, PVN BMI microinjection profoundly altered the SND bursting pattern in baroreceptor-innervated and -denervated rats. PVN BMI-induced changes in the SND bursting pattern were not observed after pretreatment with muscimol. Second, the low-frequency SND bursts recorded after PVN BMI microinjection were not coupled to PND bursts, demonstrating reduced respiratory modulation of efferent sympathetic nerve outflow after PVN GABAA receptor antagonism. Third, SND pattern changes were similar in the renal, splenic, and lumbar nerves and peak coherence values relating low-frequency bursts in sympathetic nerve pairs were significantly increased from control after PVN BMI microinjection, demonstrating a lack of selectivity in SND frequency responses to PVN GABAA receptor antagonism.
Several discharge patterns are evident in recordings from efferent sympathetic nerves, including cardiac- and respiratory-related oscillations (1, 3, 8, 9, 14, 29). The cardiac-related pattern of SND bursts in baroreceptor-innervated animals is considered the signature output of those central neural circuits involved in generation of SND (1, 8, 9). The respiratory-related pattern in efferent sympathetic nerve outflow results from the interaction of central circuits that control phrenic and sympathetic nerves, providing the neural substrate for cooperation between the cardiovascular and respiratory systems (29). The current results demonstrate that PVN BMI microinjections, but not PVN saline or cortical BMI microinjections, transform the cardiac-related SND bursting pattern in baroreceptor-innervated rats to one characterized by the presence of low-frequency bursts that are not synchronized to the cardiac cycle or PND bursts.
Under what physiological conditions might this type of SND bursting pattern be observed? Although the current results do not directly address this question, it is interesting to note that various experimental interventions, including hyperthermia (15) and hypothermia (14), transform the cardiac-related SND bursting pattern to one dominated by low-frequency bursts. Interestingly, low-frequency SND bursts recorded during hyperthermia (14) and mild-to-moderate hypothermia (15) are prominently coupled to PND bursts, whereas those recorded during deep hypothermia (15) and after PVN BMI microinjection (current study) are not. Taken together, these findings demonstrate that central sympathetic neural circuits have the capability of generating a complex array of output patterns and that PVN BMI microinjection profoundly alters the SND bursting pattern. The fact that PVN BMI-induced changes in the SND bursting pattern were not observed after muscimol pretreatment suggests a role for PVN GABAA receptors. However, BMI can exert nonselective cellular effects. For example, Debarbieux et al. (5) reported that BMI directly blocks a current mediated by small conductance channels in thalamic reticular neurons, thereby enhancing the low-threshold calcium spike and the overlying burst of sodium action potentials. Although the current results do not identify the precise cellular mechanism(s) mediating BMI-induced changes in the SND bursting pattern, they do support an important role for the PVN in SND regulation.
What is the physiological significance of SND pattern changes? We (14) have previously demonstrated that heat-induced SND pattern changes contribute significantly to increasing sympathetic nerve activity during progressive elevations in internal body temperature, establishing pattern formation as an important strategy for changing the level of SND during acute heat stress. Alternatively or in addition, it may be that the SND pattern change itself (not the associated change in the level of activity) is physiologically important. Relative to this point, Pernow et al. (24) reported that the pattern of SND bursts influences the amount of neurotransmitter released in the pig spleen. As described by Gebber (8, 9) the presence of a pattern in neuronal discharges is likely an important way to coordinate or synchronize the discharges of central neurons. With regard to the present study, although renal and splenic sympathetic nerve activity were significantly (albeit modestly) increased after PVN BMI microinjection, it may be that transformation to low-frequency SND bursts enhances the effectiveness of nerve activity innervating regionally selective target organs.
The sympathetic nervous system is capable of producing selective changes in efferent nerve outflow (2, 4, 11, 13, 15, 27). For example, nonuniform changes in the frequency-domain coupling between discharge bursts in sympathetic nerve pairs have been observed. As demonstrated using coherence analysis, the synchronized discharges in different sympathetic nerves uncouple during periods of asphyxia (12) and after sustained activation of baroreceptor afferents (3). We reasoned that the uncoupling of discharges in postganglionic nerves (reduced coherence) may provide a neural substrate for sympathetic selectivity and differentiation (12). Because the PVN is an important central nervous system site for autonomic regulation (19, 23, 25), we hypothesized that PVN BMI microinjection would reduce the coupling between discharges in different sympathetic nerves. However, the current results demonstrate similar changes in the renal, splenic, and lumbar SND bursting patterns and prominent coupling between low-frequency discharges in sympathetic nerve pairs after PVN BMI microinjection in baroreceptor-innervated and SAD rats, suggesting little regional selectivity in SND frequency responses to PVN GABAA receptor antagonism. On the other hand, the magnitude of change in the level of activity in sympathetic nerves after PVN BMI microinjection was nonuniform (i.e., renal and splenic SND were significantly increased, whereas lumbar SND was not), suggesting some degree of selectivity in SND regulation after PVN BMI microinjection. However, because MAP increased with BMI injections, variations in responses in different nerves may be indicative of regulatory differences in the baroreflex control of renal, splenic, and lumbar SND rather than reflecting selectivity in the PVN control of efferent SND.
The fact that the low-frequency SND bursts produced by PVN BMI microinjections were eliminated immediately after midbrain transection demonstrates that neural connections between the PVN and postganglionic sympathetic nerves are required for mediating PVN BMI-induced SND pattern changes. Relative to this point, it is well established that both the dorsal and medial parvocellular subdivisions of the PVN project to brain stem regions involved in autonomic regulation and to sympathetic preganglionic neurons of the intermediolateral cell column (19, 23, 25). It should be noted that, despite the fact that the BMI diffusion boundaries in the current study included the PVN, we cannot exclude the possibility that the perinuclear region of the PVN may play a role in mediating BMI-induced changes in the SND bursting pattern.
Perspectives
Central sympathetic neural networks regulate three important functional characteristics of efferent SND: 1) the basal level of activity, 2) the bursting pattern, and 3) the relationships between discharges in regionally selective sympathetic nerves and sympathetic-phrenic nerve pairs. By altering these functional characteristics, the sympathetic nervous system plays a critical role in maintaining physiological homeostasis and mediating physiological responses to acute physical stress. The central neurocircuitry mediating changes in SND functional characteristics is not well described; however, at least three lines of evidence suggest that the PVN of the hypothalamus may be an important component. First, antagonism of PVN GABAA receptors increases the level of renal and splenic sympathetic nerve activity (26, 28, current study) and alters the SND bursting pattern (current study). Second, PVN injections of DL-homocysteic acid produce nonuniform changes in the level of efferent sympathetic nerve activity (6). Third, antagonism of PVN GABAA receptors alters the cardiac- and respiratory-related patterns in efferent sympathetic nerves and enhances the coupling between low-frequency bursts in sympathetic nerve pairs (current study). These results suggest that the PVN of the hypothalamus is an important component of the central neurocircuitry regulating efferent sympathetic nerve outflow.| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grant HL-65346.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. J. Kenney, Dept. of Anatomy and Physiology, Coles Hall Rm. 228, Kansas State Univ., 1600 Denison Ave., Manhattan, KS 66506 (E-mail: Kenny{at}vet.ksu.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 9 February 2001; accepted in final form 10 May 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Barman, SM,
and
Gebber GL.
Sympathetic nerve rhythm of brain stem origin.
Am J Physiol Regulatory Integrative Comp Physiol
239:
R42-R47,
1980
2.
Barman, SM,
Gebber GL,
and
Calaresu FR.
Differential control of sympathetic nerve discharge by the brain stem.
Am J Physiol Regulatory Integrative Comp Physiol
247:
R513-R519,
1984.
3.
Claassen, DE,
Fels RJ,
and
Kenney MJ.
Altered frequency characteristics of sympathetic nerve activity after sustained elevation in arterial pressure.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R694-R703,
1998
4.
Claassen, DE,
Morgan DA,
Hirai T,
and
Kenney MJ.
Nonuniform sympathetic nerve responses after sustained elevation in arterial pressure.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1264-R1269,
1996
5.
Debarbieux, F,
Brunton J,
and
Charpak S.
Effect of bicuculline on thalamic activity: a direct blockade of IAHP in reticularis neurons.
J Neurophysiol
79:
2911-2918,
1998
6.
Deering, J,
and
Coote JH.
Paraventricular neurons elicit a volume expansion-like change of activity in sympathetic nerve to the heart and kidney in the rabbit.
Exp Physiol
85:
177-186,
2000[Abstract].
7.
De Novellis, V,
Stotz-Potter EH,
Morin SM,
Rossi F,
and
DiMicco JA.
Hypothalamic sites mediating cardiovascular effects of microinjected bicuculline and EAAs in rats.
Am J Physiol Regulatory Integrative Comp Physiol
269:
R131-R140,
1995
8.
Gebber, GL.
Central oscillators responsible for sympathetic nerve discharge.
Am J Physiol Heart Circ Physiol
239:
H143-H155,
1980
9.
Gebber, GL.
Central determinants of sympathetic nerve discharge.
In: Central Regulation of Autonomic Functions, edited by Loewy AD,
and Spyer KM.. New York: Oxford University Press, 1990, p. 126-144.
10.
Gillis, RA,
Yamada KA,
DiMicco JA,
Williford DJ,
Segal SA,
Hamosh P,
and
Norman WP.
Central
-aminobutyric acid involvement in blood pressure control.
Federation Proc
43:
32-38,
1984[ISI][Medline].
11.
Iriki, M,
Reidel W,
and
Simon E.
Regional differentiation of sympathetic nerve activity during hypothalamic heating and cooling in anesthetized rabbits.
Pflügers Arch
328:
320-331,
1971[ISI][Medline].
12.
Kenney, MJ.
Frequency characteristics of sympathetic nerve discharge in anesthetized rats.
Am J Physiol Regulatory Integrative Comp Physiol
267:
R830-R840,
1994
13.
Kenney, MJ,
Barman SM,
Gebber GL,
and
Zhong S.
Differential relationships among discharges of postganglionic sympathetic nerves.
Am J Physiol Regulatory Integrative Comp Physiol
260:
R1159-R1167,
1991
14.
Kenney, MJ,
Claassen DE,
Bishop MR,
and
Fels RJ.
Regulation of the sympathetic nerve discharge pattern during heat stress.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1992-R2001,
1998
15.
Kenney, MJ,
Claassen DE,
Fels RJ,
and
Saindon CS.
Cold stress alters characteristics of sympathetic nerve discharge bursts.
J Appl Physiol
87:
732-742,
1999
16.
Kenney, MJ,
Pickar JP,
Weiss ML,
Saindon CS,
and
Fels RJ.
Effects of midbrain and spinal cord transections on sympathetic nerve responses to heating.
Am J Physiol Regulatory Integrative Comp Physiol
278:
R1329-R1338,
2000
17.
Kocsis, B,
Gebber GL,
Barman SM,
and
Kenney MJ.
Relationships between activity of sympathetic nerve pairs: phase and coherence.
Am J Physiol Regulatory Integrative Comp Physiol
259:
R549-R560,
1990
18.
Krieger, EM.
Neurogenic hypertension in the rat.
Circ Res
15:
511-521,
1964
19.
Loewy, AD.
Central autonomic pathways.
In: Central Regulation of Autonomic Functions, edited by Loewy AD,
and Spyer KM.. New York: Oxford University Press, 1990, p. 28-43.
20.
Martin, DS,
and
Haywood JR.
Hemodynamic responses to paraventricular nucleus disinhibition with bicuculline in conscious rats.
Am J Physiol Heart Circ Physiol
265:
H1727-H1733,
1993
21.
Martin, DS,
and
Haywood JR.
Reduced GABA inhibition of sympathetic function in renal-wrapped hypertensive rats.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1523-R1529,
1998
22.
Martin, DS,
Segura T,
and
Haywood JR.
Cardiovascular responses to bicuculline in the paraventricular nucleus of the rat.
Hypertension
18:
48-55,
1991
23.
Miselis, RR,
Weiss ML,
and
Shapiro RE.
Modulation of the visceral neuraxis.
In: Circumventricular Organs and Body Fluids, edited by Gross PM.. Boca Raton, FL: CRC, 1987, p. 143-162.
24.
Pernow, J,
Schwieler J,
Kahan T,
Hjemdahl P,
Oberle J,
Gunnar Wallin B,
and
Lundberg JM.
Influence of sympathetic nerve discharge pattern on norepinephrine and neuropeptide Y release.
Am J Physiol Heart Circ Physiol
257:
H866-H872,
1989
25.
Swanson, LW,
and
Sawchenko PE.
Hypothalamic integration: organization of the paraventricular and supraoptic nuclei.
Annu Rev Neurosci
6:
269-324,
1983[ISI][Medline].
26.
Tagawa, T,
and
Dampney RAL
AT1 receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus.
Hypertension
34:
1301-1307,
1999
27.
Victor, RG,
Thoren P,
Morgan DA,
and
Mark AL.
Differential control of adrenal and renal sympathetic nerve activity during hemorrhagic hypotension in rats.
Circ Res
64:
686-694,
1989
28.
Zhang, K,
and
Patel KP.
Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R728-R734,
1998
29.
Zhong, S,
Zhou SY,
Gebber GL,
and
Barman SM.
Coupled oscillators account for the slow rhythms in sympathetic nerve discharge and phrenic nerve activity.
Am J Physiol Regulatory Integrative Comp Physiol
272:
R1314-R1324,
1997
This article has been cited by other articles:
![]() |
J. B. Park, S. Skalska, S. Son, and J. E. Stern Dual GABAA receptor-mediated inhibition in rat presympathetic paraventricular nucleus neurons J. Physiol., July 15, 2007; 582(2): 539 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Womack and R. Barrett-Jolley Activation of paraventricular nucleus neurones by the dorsomedial hypothalamus via a tachykinin pathway in rats Exp Physiol, July 1, 2007; 92(4): 671 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Ganta, N. Lu, B. G. Helwig, F. Blecha, R. R. Ganta, L. Zheng, C. R. Ross, T. I. Musch, R. J. Fels, and M. J. Kenney Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1683 - H1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lu, B. G. Helwig, R. J. Fels, S. Parimi, and M. J. Kenney Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2626 - H2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Stocker, K. J. Keith, and G. M. Toney Acute inhibition of the hypothalamic paraventricular nucleus decreases renal sympathetic nerve activity and arterial blood pressure in water-deprived rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R719 - R725. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lu, Y. Wang, F. Blecha, R. J. Fels, H. P. Hoch, and M. J. Kenney Central interleukin-1beta antibody increases renal and splenic sympathetic nerve discharge Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1536 - H1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kenney, M. L. Weiss, T. Mendes, Y. Wang, and R. J. Fels Role of paraventricular nucleus in regulation of sympathetic nerve frequency components Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1710 - H1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, M. Hiratsuka, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved Ventrolateral Medulla AT1 Receptors Support Arterial Pressure in Dahl Salt-Sensitive Rats Hypertension, March 1, 2003; 41(3): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kenney, F. Blecha, R. J. Fels, and D. A. Morgan Altered frequency responses of sympathetic nerve discharge bursts after IL-1beta and mild hypothermia J Appl Physiol, July 1, 2002; 93(1): 280 - 288. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |